HSIC

Henry Schein Inc.

Price

$77.20

return (12m)

p/e

25.52

p/bv

2.09

DIVIDEND YIELD

0.00%

HSIC price

Henry Schein

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment HSIC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals HSIC

Valuation

P/E

25.52

Sector -2.34

Industry 11.10

P/BV

2.09

Sector 2.17

Industry 3.33

P/Revenue (PSR)

0.75

Sector 2.00

Industry 1.71

EV/EBITDA

45.44

Sector -23.69

Industry -398.52

EV/EBIT

64.91

Sector -36.60

Industry -80.73

P/EBITDA

10.10

Sector -0.10

Industry 8.30

P/EBIT

14.56

Sector -2.08

Industry 5.69

P/Total Assets

0.89

Sector 1.18

Industry 1.57

P/Net Current Assets

-5.07

Sector -10.91

Industry -3.38

P/Working Capital

8.41

Sector 0.09

Industry 10.51

EPS

3.43

Sector -0.93

Industry 1.10

BVPS

41.93

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

31.19%

Sector 44.28%

Industry 29.23%

EBITDA Margin

8.02%

Sector -291.45%

Industry 4.29%

EBIT Margin

5.61%

Sector -195.44%

Industry 1.44%

Operating Margin

5.62%

Sector -25.72%

Industry 2.16%

Net Profit Margins

2.95%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.30

Sector 0.12

Industry 0.27

Profitability

ROE

8.19%

Sector -34.71%

Industry 6.97%

ROA

3.49%

Sector -28.76%

Industry 2.97%

ROIC

6.53%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

0.00%

Sector -

Industry 0.01%

Payout

0.00%

Sector -

Industry 0.54%

Debt

Current Ratio

1.36

Sector 1.87

Industry 1.51

Net Debt / EBITDA

8.11

Sector -2.18

Industry -1.68

Net Debt / EBIT

11.58

Sector -0.74

Industry -7.00

Net Debt / Equity

0.45

Sector -0.34

Industry 0.05

Gross Debt / Equity

0.48

Sector -0.64

Industry 0.35

Equity/Assets

0.43

Sector 0.43

Industry 0.46

Liabilities/Assets

0.57

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

1.54%

Sector -

Industry -

5Y Earnings CAGR

-8.94%

Sector -

Industry -

FAIR VALUE OF Henry Schein ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$77.20

Fair Value

$56.89

Upside Return potential.

-26.31%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals HSIC

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
HSIC Henry Schein Inc.	$77.20	19.76%	0.00%	25.52	2.09	8.19%	2.95%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

HSIC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Henry Schein

Henry Schein Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

34 years

Founded: 1992

1995

Time since IPO - 31 years

19.000

Employees

Henry Schein Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $10.08 billion, with shareholders equity totaling $4.82 billion.

The company employs approximately 19.000 people and operates in the Saúde sector, within the Materiais e Equipamentos Médicos industry.

Over the past 12 months, Henry Schein Inc. reported $13.38 billion in revenue, generating net income of $395.00 million.

Key financial metrics include a P/E ratio of 25.52, a price-to-book (P/B) ratio of 2.09, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker HSIC.

Market cap

$10.08 billion

Net worth

$4.82 billion

$4,822,000,000.00

Assets

$11.30 billion

$11,304,000,000.00

Total Shares Outstanding

115.00 million

115,000,000

Average Daily Trading Volume

$1.51 million

$1,513,406.00

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

HSIC

HSIC revenue and profits

Financial Results HSIC

DRAG THE FRAME TO SEE MORE DATA

HSIC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56